Dr. Agarwals Health Care Ltd. Announces Merger with Dr. Agarwal's Eye Hospital Ltd.
Dr. Agarwals Health Care Ltd. (AHCL) will merge with Dr. Agarwal's Eye Hospital Ltd. (AEHL) in a 23:2 share exchange ratio.
Reader Takeaway: Consolidation expected to boost EPS and shareholder value; shareholder vote scheduled for July 2, 2026.
What just happened
The Board of Directors of Dr. Agarwals Health Care Limited (AHCL) has approved a Scheme of Amalgamation to merge Dr. Agarwal’s Eye Hospital Limited (AEHL) with AHCL. Key dates have been set, including a meeting on July 02, 2026, for shareholders to vote on the amalgamation. The cut-off date for voting is June 03, 2026, with remote e-voting from June 07, 2026, to July 01, 2026.
Why this matters
This merger is intended to consolidate operations, streamline functions, and pool resources between the two entities. Management anticipates the amalgamation will be earnings per share (EPS) accretive from the first year post-implementation, leading to long-term shareholder value creation through improved operational and financial efficiencies.
The backstory
As of March 31, 2025, AHCL reported revenue from operations of ₹1,043.89 crore, while AEHL reported ₹397.15 crore. Based on December 31, 2025, financials, AHCL’s net worth stood at ₹1,973.87 crore. The merger aims to strengthen the combined entity's balance sheet, with the post-scheme net worth expected to be ₹2,225.44 crore for AHCL.
What changes now
The companies are moving forward with the amalgamation process, with shareholder approval being the next critical step. The NCLT-mandated meetings are scheduled to gather this approval. The share exchange ratio of 23 AHCL shares for every 2 AEHL shares is a key detail for shareholders.
Risks to watch
Shareholders need to vote in favour of the scheme for it to proceed. Final sanctions from the National Company Law Tribunal (NCLT) are required. The successful integration of operations post-merger will be crucial for realizing the anticipated efficiencies and value creation.
Peer comparison
While not explicitly provided in the filing, the healthcare sector has seen consolidation trends. Mergers in this space often aim for scale to improve service delivery and cost efficiencies, particularly in specialized areas like eye care.
Context metrics (time-bound)
- Meeting Date: July 02, 2026
- Cut-off Date for Voting: June 03, 2026
- Remote e-voting Period: June 07, 2026, to July 01, 2026
- Financials as of: March 31, 2025 (Revenue), December 31, 2025 (Net Worth)
What to track next
Investors should closely monitor the outcome of the shareholder vote on July 02, 2026. Subsequent NCLT approvals and the timeline for the completion of the integration process will be important indicators.
